CLINICAL_TRIALS
ClinicalTrials.gov record update
Peripheral Blood Stem Cell Allotransplantation for Hematological Malignancies Using Ex Vivo CD3, CD19 Depletion and CD34 Selection
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT01517035
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:36:52.685129+00:00
- Published At
- 2018-07-05T00:00:00+00:00
- Record Updated At
- 2018-07-05
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Myelodysplastic Syndrome (MDS)", "Chronic Myelogenous Leukemia", "Acute Lymphoblastic Leukemia", "CML (Chronic Myelogenous Leukemia", "CLL (Chronic Lymphocytic Leukemia)"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-07-05"- protocolSection.identificationModule.nctId
"NCT01517035"- protocolSection.identificationModule.officialTitle
"Peripheral Blood Stem Cell Allotransplantation for Hematological Malignancies Using Ex Vivo CD3, CD19 Depletion and CD34 Selection"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE1", "PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.